(Q72650153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

1 reference

Antonio Sili Scavalli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

A Spadaro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

V Riccieri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

E Taccari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

A Zoppini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 September 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

357-360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

28 October 2019

cites work

1 reference

12 December 2020

Use of monoclonal antibodies and F(ab')2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors

1 reference

12 December 2020

Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels

1 reference

12 December 2020

Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis

1 reference

12 December 2020

Clinical and laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate

1 reference

12 December 2020

Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis

1 reference

12 December 2020

A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months

1 reference

12 December 2020

Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial

1 reference

12 December 2020

The influence of chrysotherapy on serum protein and immunoglobulin levels, rheumatoid factor, and antiepithelial antibody titers

1 reference

12 December 2020

IgG rheumatoid factors and self-association of these antibodies

1 reference

12 December 2020

1 reference

12 December 2020

Chrysotherapy. suppression of immunoglobulin synthesis

1 reference

12 December 2020

IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity

1 reference

12 December 2020

Methotrexate: mechanism of action in rheumatoid arthritis

1 reference

12 December 2020

Immunologic studies of rheumatoid arthritis patients treated with methotrexate

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

1 reference

12 December 2020

Methotrexate in refractory rheumatoid arthritis

1 reference

12 December 2020

Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods

1 reference

12 December 2020

Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression

1 reference

12 December 2020

Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight–week randomized, double-blind trial

1 reference

12 December 2020

Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor

1 reference

12 December 2020

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months

1 reference

12 December 2020

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02231579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8258236%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference